XCL1



XCL1

V1VV1G2GG2S3SS3E4EE4V5VV5S6SS6D7DD7K8KK8R9RR9T10TT10C11CC11V12VV12S13SS13L14LL14T15TT15T16TT16Q17QQ17R18RR18L19LL19P20PP20V21VV21S22SS22R23RR23I24II24K25KK25T26TT26Y27YY27T28TT28I29II29T30TT30E31EE31G32GG32S33SS33L34LL34R35RR35A36AA36V37VV37I38II38F39FF39I40II40T41TT41K42KK42R43RR43G44GG44L45LL45K46KK46V47VV47... and 46 more residue(s)...... and 46 more residue(s)

SMILES None
InChIKey None
Sequence VGSEVSDKRTCVSLTTQRLPVSRIKTYTITEGSLRAVIFITKRGLKVCADPQATWVRDVVRSMDRKSNTRNNMIQTKPTGTQQSTNTAVTLTG

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

XCL1

V1VV1G2GG2S3SS3E4EE4V5VV5S6SS6D7DD7K8KK8R9RR9T10TT10C11CC11V12VV12S13SS13L14LL14T15TT15T16TT16Q17QQ17R18RR18L19LL19P20PP20V21VV21S22SS22R23RR23I24II24K25KK25T26TT26Y27YY27T28TT28I29II29T30TT30E31EE31G32GG32S33SS33L34LL34R35RR35A36AA36V37VV37I38II38F39FF39I40II40T41TT41K42KK42R43RR43G44GG44L45LL45K46KK46V47VV47... and 46 more residue(s)...... and 46 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.